Clinical trial

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT06704672

Study summary

ClinicalTrials.gov

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Accu-Chek SmartGuide CGM Solution Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Accu-Chek SmartGuide Sensor and Blinded Apps Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention SMBG Device Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-04-14

PhaseNA

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Interventions

Accu-Chek SmartGuide CGM SolutionDEVICE

Accu-Chek SmartGuide Sensor and Blinded AppsDEVICE

SMBG DeviceDEVICE

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Roche Diabetes Carecollaborator

Mapped research locations

IstanbulTurkey (Türkiye)6 WarsawPoland3 LublinPoland3 KrakowPoland1 GdanskPoland1 AdanaTurkey (Türkiye)1 NadarzynPoland1 KraśnikPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06704672 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.